PENTETATE CALCIUM TRISODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Pentetate Calcium Trisodium patents expire, and what generic alternatives are available?
Pentetate Calcium Trisodium is a drug marketed by Hameln and is included in one NDA.
The generic ingredient in PENTETATE CALCIUM TRISODIUM is pentetate calcium trisodium. There is one drug master file entry for this compound. Additional details are available on the pentetate calcium trisodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENTETATE CALCIUM TRISODIUM?
- What are the global sales for PENTETATE CALCIUM TRISODIUM?
- What is Average Wholesale Price for PENTETATE CALCIUM TRISODIUM?
Summary for PENTETATE CALCIUM TRISODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 17 |
| Clinical Trials: | 1 |
| Patent Applications: | 590 |
| What excipients (inactive ingredients) are in PENTETATE CALCIUM TRISODIUM? | PENTETATE CALCIUM TRISODIUM excipients list |
| DailyMed Link: | PENTETATE CALCIUM TRISODIUM at DailyMed |
Recent Clinical Trials for PENTETATE CALCIUM TRISODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Cancer Institute (NCI) | Phase 1/Phase 2 |
US Patents and Regulatory Information for PENTETATE CALCIUM TRISODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hameln | PENTETATE CALCIUM TRISODIUM | pentetate calcium trisodium | SOLUTION;INHALATION, INTRAVENOUS | 021749-001 | Aug 11, 2004 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
